Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, announced the official opening of its latest Good Manufacturing Practice (GMP) facility in Singapore. The GMP will support cell manufacturing for immunotherapies in Singapore and across the …
Vertex and Lonza announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 and VX-264 programs that are currently in clinical trials. Vert…
Zimmer Biomet Holdings a global medical technology leader, officially opened an expanded office and APAC Global Business Services Center (GBS) in Kuala Lumpur, Malaysia. The momentous event was officiated by Datuk Muhammad Azmi Zulkifli, Chief Executive Officer of InvestKL and Bryan Hanson, Chairman, President and Ch…
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, is substantially extending its North American footprint and expanding global capacity with a new 200,000-square-foot manufacturing plant in Madison, Wisconsin – the second TekniPlex Healthcare facility in…
Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced the opening of its first, state-of-the-art manufacturing facility in Brisbane, Queensland. The custom-built 5,500 square meter (60,000 square feet) Vaxxas Biomedical Facility will serve as the company…
Enzene Biosciences, a global biotech company based in Pune, will open its state-of-the-art biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell. Operations in the new facility, the company’s first location outside of India, are expected to begin in June 2024. As a Contract Develop…
Bristol Myers Squibb nnounced that the U.S. Food and Drug Administration (FDA) has approved commercial production at the company’s newest cell therapy manufacturing facility in Devens, Massachusetts. The Devens site is a critical component of BMS’ expanding global cell therapy manufacturing footprint for long-term su…
Proteintech announces its Manchester office has moved and expanded. The new site is based at Transmission, a brand-new building in Enterprise City, the fastest-growing industrial district of the city center. The new space has doubled the footprint of the Manchester site to accommodate the expansion of operations, sale…
Novo Nordisk announced plans to invest 15.9 billion Danish kroner starting in 2023 to expand an existing Active Pharmaceutical Ingredient (API) production facility in Denmark for the future portfolio within serious chronic diseases. The investment comes as Novo Nordisk marks the 100th anniversary of its founding in D…
Telix Pharmaceuticals Limited welcomes Willy Borsus, Vice-President of Wallonia, Minister of Economy, Research and Innovation, Digital, Agriculture, Urban Planning and Regional Planning to officially open Telix Manufacturing Solutions, the Company's radiopharmaceutical production facility located in Brussels South (Se…
Page 53 of 60